# Study to Optimize Insulin Treatment by Basal Regimen With Insulin Glargine in Type-2-Diabetic Patients Previously Uncontrolled on Premixed Insulin

> **NCT00693771** · PHASE4 · COMPLETED · sponsor: **Sanofi** · enrollment: 313 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Insulin Glargine

## Key facts

- **NCT ID:** NCT00693771
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 313 (ACTUAL)
- **Last updated:** 2011-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00693771

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00693771, "Study to Optimize Insulin Treatment by Basal Regimen With Insulin Glargine in Type-2-Diabetic Patients Previously Uncontrolled on Premixed Insulin". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00693771. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*